Tuesday, February 14th |
|
|
|
15:00-18:00 |
REGISTRATION |
|
17:00-18:45 |
RECEPTION |
Refreshments will be served |
18:55-19:00 |
WELCOME |
Dr. Balu Balasubramanian
Pharma Innovation Sourcing Center, USA &
Ms.Bindu Ajit, Biocon Academy |
19:00-21:00 |
Lectures 1 and 2
Basic Principles of Medicinal Chemistry |
Prof. Thomas Prisinzano,
Univ. of Kansas, USA |
Wednesday, February 15th |
8:30-9:30 |
Lecture 3
Target Identification and Validation |
Dr. Manjunath Ramarao
Biocon-BMS R&D Center, India |
9:45-10:45 |
Lecture 4
Hit Identification: High-Throughput / Phenotypic/
Virtual / Fragment screening |
Dr. Indranil Mukhopadhyay Glenmark, India |
11:00-11:15 |
TEA BREAK |
|
11:15- 12:15 |
Lecture 5
Enzymes, Receptors and Ion Channels |
Dr. Manjunath Ramarao
Biocon-BMS R&D Center, India |
12:30-1:30 |
LUNCH |
|
1:30-2:30 |
Lecture 6
Hit-to-Lead Process |
Prof. Craig Lindsley
Vanderbilt University, USA |
2:45-3:45 |
Lecture 7
Lead Optimization |
Prof. Craig Lindsley
Vanderbilt University, USA |
4:00-4:15 |
TEA BREAK |
|
4:15-5:15 |
Lecture 8
Improving Drug Candidates by Design – Applications of Efficiency Metrics |
Dr. Nick Meanwell
Bristol-Myers Squibb, USA |
|
|
|
Thursday, February 16th |
8:30-9:30 |
Lecture 9
Toxicology in early discovery & development- Screening and translational medicine |
Dr. Bruce Car
Bristol-Myers Squibb, USA |
9:45-10:45 |
Lecture 10
Designing Around Toxicophores in Drug Discovery |
Dr. Nick Meanwell
Bristol-Myers Squibb, USA |
11:00-11:15 |
TEA BREAK |
|
11:15-12:15 |
Lecture 11
Protein Binding |
Dr. Swamy Yeleswaram
Incyte, USA |
12:30-1:30 |
LUNCH BREAK |
|
1:30-2:30 |
Lecture 12
Drug Metabolism and PK |
Dr. Swamy Yeleswaram
Incyte, USA |
2:45-3:45 |
Lecture 13
Bioisosteres in Drug Design – Some Tactical Applications |
Dr. Nick Meanwell
Bristol-Myers Squibb, USA |
4:00-4:15 |
TEA BREAK |
|
4:15-5:15 |
Lecture 14
Special Topic: Applications of Fluorine in Drug Design and Discovery |
Dr. Nick Meanwell
Bristol-Myers Squibb, USA |
|
|
|
Friday, February 17th |
8:30-9:30 |
Lecture 15
Structure Based Design of Small Molecule GK-GKRP Disruptors as a Novel Treatment for Diabetes |
Dr. Kate Ashton
Amgen, USA |
9:45-10:45 |
Lecture 16
G-Protein Coupled Receptors |
Prof. Craig Lindsley
Vanderbilt University, USA |
11:00-11:15 |
TEA BREAK |
|
11:15-12:15 |
Lecture 17
Pharmaceutics and Developability Characteristics of Drug Candidates |
Dr. Nancy Barbour
Bristol-Myers Squibb, USA |
12:30-1:30 |
LUNCH BREAK |
|
1:30-2:30 |
Lecture-18
Clinical Development and
Translational Medicine |
Dr. Narendra Maharaj
Lupin, India |
2:45-3:45 |
Lecture 19
Case History:
HIV-1 Attachment Inhibitors |
Dr. Nick Meanwell
Bristol-Myers Squibb, USA |
4:00-5:00 |
Lecture 20
Case History:
Saroglitazar (Lipaglyn®) for Treatment of
Dyslipidemia and Hypertriglyceridemia in Type II diabetes |
Dr. Mukul Jain
Zydus, India |
|
KEYNOTE LECTURES |
|
6:00-6:30 |
Current Trends in Indian Pharma & Biotech |
Ms. Kiran Mazumdar Shaw
Biocon, India |
6:30-7:00 |
Future Trends in Drug Discovery |
Dr. Bruce Car
Bristol-Myers Squibb, USA |
7:00-9:15 |
RECEPTION AND DINNER |
|
Saturday, February 18th |
8:30-9:30 |
Lecture-21
Introduction to Biologics |
Dr. Narendra Chirmule
Biocon, India |
9:45-10:45 |
Lecture-22
Beyond Monoclonal Antibodies |
Dr. Narendra Chirmule
Biocon, India |
11:00-12:15 |
Lecture, 23
Case History:
Ruxolitinib (Jakafi®) for Treatment of Polycythemia Vera and Myelofibrosis |
Dr. Swamy Yeleswaram Incyte, USA |
12:15-12:30 |
Concluding Remarks |
Dr. Bill Greenlee
Medchem Discovery Consulting, USA
&
SS.Easwaran,
Biocon Academy |
12:30-1:30 |
LUNCH |
|
|
|
|
1:30 |
CLOSE OF MCADDI 2019 |
|
|
|
|
